Investor profile
Double Point Ventures has backed 1 European tech company across 1 funding round in 2024, joining rounds totalling €9.9M. Most active in Healthtech. Data as of 6 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Immunos Therapeutics | Switzerland | 1 | €9.9M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Immunos Therapeutics | Series C | €9.9M | 2024-09 |
